Fluid Systems - Drug Delivery Systems
Biological
BAXTER HEALTHCARE
Total Payments
$131,661
Transactions
70
Doctors
54
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $425.41 | 16 | 12 |
| 2023 | $910.33 | 3 | 1 |
| 2022 | $35,656 | 25 | 21 |
| 2021 | $67,079 | 12 | 8 |
| 2020 | $6,510 | 8 | 7 |
| 2019 | $5,330 | 5 | 5 |
| 2017 | $15,750 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $69,585 | 4 | 52.9% |
| Consulting Fee | $57,290 | 44 | 43.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,030 | 1 | 3.1% |
| Food and Beverage | $609.23 | 20 | 0.5% |
| Travel and Lodging | $146.02 | 1 | 0.1% |
Payments by Type
Research
$69,585
4 transactions
General
$62,076
66 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EVALUATION OF STARLING SV PLR IN THE RAPID RESPONSE TO HYPOTENSIVE HOSPITALIZED PATIENTS | Baxter Healthcare | $61,085 | 0 |
| Use of Cheetah non-invasive cardiac monitoring system to guide discontinuation of postpartum magnesium sulfate in women with severe preeclampsia- A pilot randomized control trial | Baxter Healthcare | $5,000 | 0 |
| Use of Cheetah non-invasive cardiac monitoring system to guide discontinuation of postpartum magnesium sulfate in women with severe preeclampsia: A pilot randomized control trial | Baxter Healthcare | $3,500 | 0 |
Top Doctors Receiving Payments for Fluid Systems - Drug Delivery Systems
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chicago, IL | $87,866 | 11 |
| , MD | Emergency Medicine | Nashville, TN | $4,030 | 1 |
| , MD | Anesthesiology | West Hollywood, CA | $3,995 | 1 |
| , M.D | Anesthesiology | La Palma, CA | $3,995 | 1 |
| , MD | Anesthesiology | Fullerton, CA | $3,995 | 1 |
| , M.D | Anesthesiology | Long Beach, CA | $3,995 | 1 |
| , M.D | Anesthesiology | Glendale Heights, IL | $1,453 | 1 |
| , MD | Anesthesiology | Chicago, IL | $1,453 | 1 |
| , MD | Anesthesiology | Chicago, IL | $1,453 | 1 |
| , M.D | Anesthesiology | Chicago, IL | $1,453 | 1 |
| , MD | Anesthesiology | Kankakee, IL | $1,453 | 1 |
| Bernard Pygon | Anesthesiology | Chicago, IL | $1,453 | 1 |
| , M.D | Pain Medicine | Chicago, IL | $1,453 | 1 |
| , M.D | Anesthesiology | Berwyn, IL | $1,453 | 1 |
| , RN, CRNA | Registered Nurse | Los Angeles, CA | $1,190 | 1 |
| , CRNA | Nurse Anesthetist, Certified Registered | Tustin, CA | $1,190 | 1 |
| , CRNA | Nurse Anesthetist, Certified Registered | Riverside, CA | $1,190 | 1 |
| , MD | Critical Care Medicine | Providence, RI | $600.00 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Irvington, NY | $550.00 | 2 |
| , CRNA | Nurse Anesthetist, Certified Registered | Geneva, IL | $490.00 | 1 |
| , CRNA | Nurse Anesthetist, Certified Registered | Chicago, IL | $490.00 | 1 |
| , CRNA | Nurse Anesthetist, Certified Registered | Chicago, IL | $490.00 | 1 |
| , CRNA, APN | Nurse Anesthetist, Certified Registered | Chicago, IL | $490.00 | 1 |
| , CRNA | Registered Nurse | Chicago, IL | $490.00 | 1 |
| , M.D | Diagnostic Ultrasound | Brighton, MA | $450.00 | 1 |
Ad
Manufacturing Companies
- Baxter Healthcare $113,100
- BAXTER HEALTHCARE $18,560
Product Information
- Type Biological
- Total Payments $131,661
- Total Doctors 54
- Transactions 70
About Fluid Systems - Drug Delivery Systems
Fluid Systems - Drug Delivery Systems is a biological associated with $131,661 in payments to 54 healthcare providers, recorded across 70 transactions in the CMS Open Payments database. The primary manufacturer is BAXTER HEALTHCARE.
Payment data is available from 2017 to 2024. In 2024, $425.41 was paid across 16 transactions to 12 doctors.
The most common payment nature for Fluid Systems - Drug Delivery Systems is "Unspecified" ($69,585, 52.9% of total).
Fluid Systems - Drug Delivery Systems is associated with 3 research studies, including "EVALUATION OF STARLING SV PLR IN THE RAPID RESPONSE TO HYPOTENSIVE HOSPITALIZED PATIENTS" ($61,085).